CA3291315A1 - Méthodes thérapeutiques et compositions de traitement des troubles du mouvement - Google Patents

Méthodes thérapeutiques et compositions de traitement des troubles du mouvement

Info

Publication number
CA3291315A1
CA3291315A1 CA3291315A CA3291315A CA3291315A1 CA 3291315 A1 CA3291315 A1 CA 3291315A1 CA 3291315 A CA3291315 A CA 3291315A CA 3291315 A CA3291315 A CA 3291315A CA 3291315 A1 CA3291315 A1 CA 3291315A1
Authority
CA
Canada
Prior art keywords
compositions
therapeutic methods
movement disorders
treating movement
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3291315A
Other languages
English (en)
Inventor
Bernard Mayer RAVINA
Maria G. BECONI-BARKER
Judith Dunn
Mark Rogge
Original Assignee
Vima Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vima Therapeutics Inc filed Critical Vima Therapeutics Inc
Publication of CA3291315A1 publication Critical patent/CA3291315A1/fr
Pending legal-status Critical Current

Links

CA3291315A 2023-05-05 2024-05-03 Méthodes thérapeutiques et compositions de traitement des troubles du mouvement Pending CA3291315A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/464,409 2023-05-05
US63/615,960 2023-12-29

Publications (1)

Publication Number Publication Date
CA3291315A1 true CA3291315A1 (fr) 2024-11-14

Family

ID=

Similar Documents

Publication Publication Date Title
EP4352079A4 (fr) Compositions et méthodes pour traiter des troubles neurofibromatiques
CA3263315A1 (fr) Nouvelles compositions pharmaceutiques et méthodes de traitement de troubles psychiatriques
EP4157219A4 (fr) Méthodes et compositions permettant de traiter des maladies et des états de la rétine
EP4135661A4 (fr) Compositions et méthodes de traitement de troubles neurologiques
EP4175978A4 (fr) Compositions et méthodes pour traiter des maladies médiées par crp
CA3261972A1 (fr) Compositions et méthodes pour le traitement de troubles métaboliques
CA3291315A1 (fr) Méthodes thérapeutiques et compositions de traitement des troubles du mouvement
AU2024363527A1 (en) Compositions and methods for treating gastrointestinal-related diseases and disorders
CA3308877A1 (fr) Compositions et méthodes de traitement de maladies et de troubles gastro-intestinaux
CA3305935A1 (fr) Compositions et méthodes pour traiter des troubles douloureux
AU2024374758A1 (en) Compositions and methods for treating skin disorders
CA3297601A1 (fr) Procédés et compositions pour le traitement de troubles associés à ctnnb1
HK40131011A (en) Methods and compositions for treating hsd-1-mediated disorders
CA3278656A1 (fr) Procédés et compositions pour traiter des troubles médiés par hsd-1
AU2022903123A0 (en) Compositions and methods for treating disorders
CA3285901A1 (fr) Compositions de microbiote et méthodes de traitement de troubles
AU2023900704A0 (en) Microbiota Compositions and Methods for Treating Disorders
HK40110376A (en) Compositions and methods for treating neurofibromatic disorders
AU2022901710A0 (en) Compositions and methods for treating neurological disorders
AU2022900640A0 (en) Compositions and methods for treating neurological disorders
HK40117828A (en) Methods and compositions for treating igg4- related diseases
HK40115072A (en) Compositions and methods for the treatment of pcdh19 related disorders
HK40110975A (en) Methods and compositions for treating ocular disorders and diseases
HK40109314A (en) Methods and compositions for treating ocular diseases and disorders
IL326321A (en) Methods and compositions for treating CTNNB1-related disorders